<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34782793</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS.</ArticleTitle><Pagination><StartPage>1673</StartPage><EndPage>1685</EndPage><MedlinePgn>1673-1685</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-021-00944-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating disorder in which motor neurons degenerate, the causes of which remain unclear. In particular, the basis for selective vulnerability of spinal motor neurons (sMNs) and resistance of ocular motor neurons to degeneration in ALS has yet to be elucidated. Here, we applied comparative multi-omics analysis of human induced pluripotent stem cell-derived sMNs and ocular motor neurons to identify shared metabolic perturbations in inherited and sporadic ALS sMNs, revealing dysregulation in lipid metabolism and its related genes. Targeted metabolomics studies confirmed such findings in sMNs of 17 ALS (SOD1, C9ORF72, TDP43 (TARDBP) and sporadic) human induced pluripotent stem cell lines, identifying elevated levels of arachidonic acid. Pharmacological reduction of arachidonic acid levels was sufficient to reverse ALS-related phenotypes in both human sMNs and in vivo in Drosophila and SOD1<sup>G93A</sup> mouse models. Collectively, these findings pinpoint a catalytic step of lipid metabolism as a potential therapeutic target for ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hojae</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Robert Packard Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jae Jin</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0001-8317-437X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Na Young</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, College of Medicine, Dong-A University, Busan, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubey</LastName><ForeName>Sandeep Kumar</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-2424-1031</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Taeyong</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4147-3635</Identifier><AffiliationInfo><Affiliation>Department of Biology, San Diego State University, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Su Bin</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0003-1752-7039</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Seong-Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Shinwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovlyagina</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyung-Tai</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seongjun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0130-161X</Identifier><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Yohan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9249-8664</Identifier><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyesoo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sung-Ung</ForeName><Initials>SU</Initials><Identifier Source="ORCID">0000-0002-8393-2588</Identifier><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Mi-Ryoung</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-4756-3700</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Medicine Program, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maragakis</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-7311-9614</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Young Bin</ForeName><Initials>YB</Initials><Identifier Source="ORCID">0000-0002-4333-3847</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, College of Medicine, Dong-A University, Busan, Korea. ybhong@dau.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Korea. ybhong@dau.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eoh</LastName><ForeName>Hyungjin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8774-6400</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, CA, USA. heoh@usc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Gabsang</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5052-5927</Identifier><AffiliationInfo><Affiliation>Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. glee48@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. glee48@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Robert Packard Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. glee48@jhmi.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA. glee48@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR070751</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS093213</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS117604</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Neurosci. 2021 Dec 21;:</RefSource><PMID Version="1">34934204</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34782793</ArticleId><ArticleId IdType="mid">NIHMS1741142</ArticleId><ArticleId IdType="pmc">PMC8639773</ArticleId><ArticleId IdType="doi">10.1038/s41593-021-00944-z</ArticleId><ArticleId IdType="pii">10.1038/s41593-021-00944-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH Jr &amp; Cleveland DW Decoding ALS: from genes to mechanism. Nature 539, 197 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan R &amp; Bradley WG Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 18, 271&#x2013;280 (1985).</Citation></Reference><Reference><Citation>Saxena S &amp; Caroni P Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35&#x2013;48 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21745636</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nature medicine 24, 1579 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell stem cell 14, 781&#x2013;795 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nature neuroscience 22, 167 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z. e. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nature neuroscience 22, 180 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminski HJ, Richmonds CR, Kusner LL &amp; Mitsumoto H Differential susceptibility of the ocular motor system to disease. Annals of the New York Academy of Sciences 956, 42&#x2013;54 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11960792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW &amp; Rothstein JD From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature reviews neuroscience 2, 806 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81, 333&#x2013;348 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I et al. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Scientific reports 6, 25960 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4867585</ArticleId><ArticleId IdType="pubmed">27180807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni EO et al. Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity. Nature neuroscience 16, 1219 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820498</ArticleId><ArticleId IdType="pubmed">23872598</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I et al. Modeling motor neuron resilience in ALS using stem cells. Stem cell reports (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6565614</ArticleId><ArticleId IdType="pubmed">31080111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD &amp; Mattson MP Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress&#x2013;induced death of motor neurons in amyotrophic lateral sclerosis. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 52, 448&#x2013;457 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilopoulos S et al. Cholestenoic acids regulate motor neuron survival via liver X receptors. The Journal of clinical investigation 124, 4829&#x2013;4842 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4347238</ArticleId><ArticleId IdType="pubmed">25271621</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattyn A, Hirsch M, Goridis C &amp; Brunet J-F Control of hindbrain motor neuron differentiation by the homeobox gene Phox2b. Development 127, 1349&#x2013;1358 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10704382</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash N et al. Nkx6-1 controls the identity and fate of red nucleus and oculomotor neurons in the mouse midbrain. Development 136, 2545&#x2013;2555 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2729334</ArticleId><ArticleId IdType="pubmed">19592574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan KB, Agarwala S &amp; Ragsdale CW PHOX2A regulation of oculomotor complex nucleogenesis. Development 137, 1205&#x2013;1213 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2835333</ArticleId><ArticleId IdType="pubmed">20215354</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q et al. Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development. Development 138, 3399&#x2013;3408 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21752929</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano M et al. Homozygous mutations in ARIX (PHOX2A) result in congenital fibrosis of the extraocular muscles type 2. Nature genetics 29, 315 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11600883</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh Y et al. Functional coupling with cardiac muscle promotes maturation of hPSC-derived sympathetic neurons. Cell Stem Cell 19, 95&#x2013;106 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4996639</ArticleId><ArticleId IdType="pubmed">27320040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriks S et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson&#x2019;s disease. Nature 480, 547 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245796</ArticleId><ArticleId IdType="pubmed">22056989</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang M, Luo SX, Tang V &amp; Huang EJ Temporal and spatial requirements of Smoothened in ventral midbrain neuronal development. Neural development 8, 8 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680293</ArticleId><ArticleId IdType="pubmed">23618354</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielian PS &amp; McMahon AP Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development. Nature 383, 332 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8848044</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsarovina K et al. Essential role of Gata transcription factors in sympathetic neuron development. Development 131, 4775&#x2013;4786 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15329349</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler J et al. Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9. Neuron 23, 675&#x2013;687 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10482235</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M-R et al. Islet-to-LMO stoichiometries control the function of transcription complexes that specify motor neuron and V2a interneuron identity. Development 136, 2923&#x2013;2932 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723064</ArticleId><ArticleId IdType="pubmed">19666821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewcock JW, Genoud N, Lettieri K &amp; Pfaff SL The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron 56, 604&#x2013;620 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18031680</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidato S, Barrett C &amp; Guthrie S Patterning of motor neurons by retinoic acid in the chick embryo hindbrain in vitro. Molecular and Cellular Neuroscience 23, 81&#x2013;95 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12799139</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder EL et al. Retinoic acid-mediated regulation of GLI3 enables efficient motoneuron derivation from human ESCs in the absence of extrinsic SHH activation. Journal of Neuroscience 35, 11462&#x2013;11481 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4540792</ArticleId><ArticleId IdType="pubmed">26290227</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I et al. Modeling motor neuron resilience in ALS using stem cells. Stem cell reports 12, 1329&#x2013;1341 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6565614</ArticleId><ArticleId IdType="pubmed">31080111</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund E, Karlsson M, Osborn T, Ludwig W &amp; Isacson O Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain 133, 2313&#x2013;2330 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139939</ArticleId><ArticleId IdType="pubmed">20826431</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena GN et al. Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Molecular neurobiology 53, 2222&#x2013;2240 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J &amp; Wishart DS Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Current protocols in bioinformatics 55, 14.10. 11&#x2013;14.10. 91 (2016).</Citation></Reference><Reference><Citation>Lawton KA et al. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15, 362&#x2013;370 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24984169</ArticleId></ArticleIdList></Reference><Reference><Citation>Jatana M et al. Inhibition of NF-&#x3ba;B activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. Journal of neuroinflammation 3, 12 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1526713</ArticleId><ArticleId IdType="pubmed">16689995</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;fner A-K, Kahnt AS &amp; Steinhilber D Beyond leukotriene formation&#x2013;the noncanonical functions of 5-lipoxygenase. Prostaglandins &amp; other lipid mediators (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30930090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Pearman AT, Zimmerman GA, McIntyre TM &amp; Prescott SM Intracellular unesterified arachidonic acid signals apoptosis. Proceedings of the National Academy of Sciences 97, 11280&#x2013;11285 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17191</ArticleId><ArticleId IdType="pubmed">11005842</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo MT et al. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer research 59, 5047&#x2013;5053 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10519422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JQ, Zhou QX, Liu BZ &amp; He BC Protection of Mouse Brain from Aluminum&#x2010;induced Damage by Caffeic Acid. CNS neuroscience &amp; therapeutics 14, 10&#x2013;16 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494061</ArticleId><ArticleId IdType="pubmed">18482095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishayee K &amp; Khuda-Bukhsh AR 5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy. Acta Biochim Biophys Sin 45, 709&#x2013;719 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23752617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pergola C &amp; Werz O 5-Lipoxygenase inhibitors: a review of recent developments and patents. Expert opinion on therapeutic patents 20, 355&#x2013;375 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20180620</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proceedings of the National Academy of Sciences 110, 7778&#x2013;7783 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. Journal of lipid research 58, 267&#x2013;278 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>An D et al. Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons. eLife 8, e44423 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6594754</ArticleId><ArticleId IdType="pubmed">31157617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehne A et al. Acute activation of oxidative pentose phosphate pathway as first-line response to oxidative stress in human skin cells. Molecular cell 59, 359&#x2013;371 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26190262</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra KC &amp; Hay N The pentose phosphate pathway and cancer. Trends in biochemical sciences 39, 347&#x2013;354 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329227</ArticleId><ArticleId IdType="pubmed">25037503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R et al. Poly (GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 92, 383&#x2013;391 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrus PK, Fleck TJ, Gurney ME &amp; Hall ED Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. Journal of neurochemistry 71, 2041&#x2013;2048 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9798929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC et al. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences 112, 8100&#x2013;8105 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491749</ArticleId><ArticleId IdType="pubmed">26056266</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC et al. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. Journal of Neuroscience 40, 9137&#x2013;9147 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673008</ArticleId><ArticleId IdType="pubmed">33051352</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s&#x2010;Benito P et al. Lipid alterations in human frontal cortex in ALS&#x2010;FTLD&#x2010;TDP43 proteinopathy spectrum are partly related to peroxisome impairment. Neuropathology and Applied Neurobiology 47, 544&#x2013;563 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248144</ArticleId><ArticleId IdType="pubmed">33332650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nature Medicine, 1&#x2013;8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Das UN Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review. Journal of advanced research 11, 43&#x2013;55 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052660</ArticleId><ArticleId IdType="pubmed">30034875</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomonov Y, Hadad N &amp; Levy R Reduction of cytosolic phospholipase A 2 &#x3b1; upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of neuroinflammation 13, 1&#x2013;12 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888471</ArticleId><ArticleId IdType="pubmed">27250836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallima H &amp; El Ridi R Arachidonic acid: physiological roles and potential health benefits&#x2013;a review. Journal of advanced research 11, 33&#x2013;41 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052655</ArticleId><ArticleId IdType="pubmed">30034874</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Scientific reports 7, 1&#x2013;10 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AB et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Scientific reports 9, 1&#x2013;14 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>West M et al. The arachidonic acid 5&#x2010;lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor &#x3b1; activation of microglia and extends survival of G93A&#x2010;SOD1 transgenic mice. Journal of neurochemistry 91, 133&#x2013;143 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15379894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA et al. Genome engineering using the CRISPR-Cas9 system. Nature protocols 8, 2281 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockemeyer D et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nature biotechnology 29, 731 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3152587</ArticleId><ArticleId IdType="pubmed">21738127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali P et al. RNA-guided human genome engineering via Cas9. Science 339, 823&#x2013;826 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712628</ArticleId><ArticleId IdType="pubmed">23287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF et al. Poly (GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Science translational medicine 9, eaai7866 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad AA et al. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia 64, 1154&#x2013;1169 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi IY et al. Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model. Cell reports 15, 2301&#x2013;2312 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27239027</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson JA et al. Embryonic stem cell lines derived from human blastocysts. science 282, 1145&#x2013;1147 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9804556</ArticleId></ArticleIdList></Reference><Reference><Citation>Riera M et al. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations. Stem cell research 35, 101385 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30685614</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN et al. G4C2 repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron 107, 1124&#x2013;1140. e1111 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784695</ArticleId><ArticleId IdType="pubmed">19693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers SM et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature biotechnology 27, 275 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756723</ArticleId><ArticleId IdType="pubmed">19252484</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y et al. Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nature biotechnology 35, 154 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5516899</ArticleId><ArticleId IdType="pubmed">28112759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H et al. Slit and Semaphorin signaling governed by Islet transcription factors positions motor neuron somata within the neural tube. Experimental neurology 269, 17&#x2013;27 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4446133</ArticleId><ArticleId IdType="pubmed">25843547</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattyn A, Morin X, Cremer H, Goridis C &amp; Brunet J-F Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 124, 4065&#x2013;4075 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9374403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S-Y et al. Genome-wide RNA-Seq of human motor neurons implicates selective ER stress activation in spinal muscular atrophy. Cell stem cell 17, 569&#x2013;584 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839185</ArticleId><ArticleId IdType="pubmed">26321202</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15&#x2013;21 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ &amp; Smyth GK edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Law CW, Chen Y, Shi W &amp; Smyth GK voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome biology 15, R29 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053721</ArticleId><ArticleId IdType="pubmed">24485249</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ &amp; Smyth GK Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25, 765&#x2013;771 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2654802</ArticleId><ArticleId IdType="pubmed">19176553</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, Han Y &amp; He Q-Y clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a journal of integrative biology 16, 284&#x2013;287 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Eoh H &amp; Rhee KY Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences 110, 6554&#x2013;6559 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631649</ArticleId><ArticleId IdType="pubmed">23576728</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S-K, Jurata LW, Funahashi J, Ruiz EC &amp; Pfaff SL Analysis of embryonic motoneuron gene regulation: derepression of general activators function in concert with enhancer factors. Development 131, 3295&#x2013;3306 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15201216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai G et al. Presenilin-dependent receptor processing is required for axon guidance. Cell 144, 106&#x2013;118 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3034090</ArticleId><ArticleId IdType="pubmed">21215373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC et al. Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotrophic Lateral Sclerosis 11, 38&#x2013;45 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K-T et al. ISL1-based LIM complexes control Slit2 transcription in developing cranial motor neurons. Scientific reports 6, 36491 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098159</ArticleId><ArticleId IdType="pubmed">27819291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritson GP et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. Journal of Neuroscience 30, 7729&#x2013;7739 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2890254</ArticleId><ArticleId IdType="pubmed">20519548</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J &amp; Wishart DS MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26, 2342&#x2013;2344 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20628077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>